Atlas Venture — 2015 Investments
7 investments dated 2015 · listed companies and verified rows first · show all
BiotechCambridge, US
Nessan Bermingham(Executive Officer, Director)Jose Rivera(Executive Officer)Carl Gordon(Director)Jean-Francois Formela(Director)John Leonard(Executive Officer, Director)Rachel Haurwitz(Director)
Board seatJean-François Formela· per SEC Form D
BiotechArlington, US
Darius Kharabi(Executive Officer)Todd Bazemore(Executive Officer)Mark Iwicki(Executive Officer, Director)Mary Reumuth(Executive Officer)Kim Brazzell(Executive Officer)Charles McDermott(Executive Officer)
Board seatKevin Bitterman· per SEC Form D · $7M raise · filed Aug 2015
HealthtechMalvern, US
Mark R. Bausinger(Executive Officer)Stephen Campe(Director)Robert Kuhling(Director)Liam Ratcliffe(Director)P. Sherrill Neff(Director)Wilfred Jaeger(Director)
Board seatKevin Bitterman· per SEC Form D · $34.3M raise · filed May 2015
HealthtechPortland, US
Edward McNamara(Director)Kevin Bitterman(Director)Yumin Choi(Director)Benjamin Shaw(Executive Officer, Director)Kerry Muse(Director)David Shaw(Director)
Board seatKevin Bitterman· per SEC Form D · $52.3M raise · filed Jul 2015
BiotechSt. Louis, US
Charles Bolten(Director)Rick Ryan(Director)Rajesh Devraj(Executive Officer, Director)John Talley(Director)Robert W. Karr(Executive Officer, Director)Eduardo Martinez(Director)
Board seatRajesh Devraj· per SEC Form D · $2.7M raise · filed Dec 2016
BiotechCambridge, US
Jean-Francois Formela(Director)Rick Lundberg(Executive Officer)Alan Crane(Director)David Madden(Director)Marian Nakada(Director)Brian Gallagher(Director)
Board seatKevin BittermanJean-François Formela· per SEC Form D · $20.2M raise · filed May 2020
BiotechCambridge, US
Brian Gallagher(Director)Jean- Francois Formela(Director)Joshua Resnick(Director)Robert Prentiss(Executive Officer)Daniel Lynch(Director)Ronald C. Renaud, Jr.(Executive Officer, Director)
Board seatJean-François Formela· per SEC Form D · $47.5M raise · filed May 2019
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.